单倍体相合干细胞移植治疗多发性骨髓瘤的安全性和有效性 - Suppr

Safety and efficacy of haploidentical stem cell transplantation for multiple myeloma.

作者信息

Chen Yao, Lu Jin, Xu Lan-Ping, Chen Huan, Zhang Xiao-Hui, Wang Feng-Rong, Chen Yu-Hong, Wang Yu, Liu Kai-Yan, Huang Xiao-Jun

机构信息

Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.

Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing, China.

出版信息

Bone Marrow Transplant. 2018 Apr;53(4):507-510. doi: 10.1038/s41409-017-0069-1. Epub 2018 Jan 12.

DOI:10.1038/s41409-017-0069-1

PMID:29330397

Abstract

摘要

相似文献

Safety and efficacy of haploidentical stem cell transplantation for multiple myeloma.单倍体相合干细胞移植治疗多发性骨髓瘤的安全性和有效性

Bone Marrow Transplant. 2018 Apr;53(4):507-510. doi: 10.1038/s41409-017-0069-1. Epub 2018 Jan 12.

Clinical and molecular remission following reduced intensity conditioning and allogeneic transplantation in a patient with refractory multiple myeloma.一名难治性多发性骨髓瘤患者在接受减低剂量预处理和异基因移植后的临床及分子缓解

Haematologica. 2002 Dec;87(12):ECR41.

Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database.未处理的单倍体相合与匹配的非亲缘供者异基因干细胞移植用于首次缓解期的成年急性髓系白血病患者：一项将北京方案与欧洲血液与骨髓移植协会（EBMT）数据库进行配对匹配的回顾性比较研究

Haematologica. 2016 Aug;101(8):e352-4. doi: 10.3324/haematol.2015.140509. Epub 2016 Apr 14.

Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.复发至先前自体移植状态和慢性移植物抗宿主病是多发性骨髓瘤患者接受基于美法仑/氟达拉滨的减低剂量异基因干细胞移植结局的最强预后因素。

Biol Blood Marrow Transplant. 2004 Oct;10(10):698-708. doi: 10.1016/j.bbmt.2004.06.002.

Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC).异基因干细胞移植后沙利度胺挽救疗法用于多发性骨髓瘤：来自法语国家骨髓瘤研究组（IFM）和法国骨髓移植与细胞治疗协会（SFGM-TC）的一项回顾性研究。

Bone Marrow Transplant. 2005 Jan;35(2):165-9. doi: 10.1038/sj.bmt.1704756.

Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation in First Complete Remission Can Abrogate the Poor Outcomes of Children with Acute Myeloid Leukemia Resistant to the First Course of Induction Chemotherapy.首次完全缓解时进行未处理的单倍体相合造血干细胞移植可消除对首个诱导化疗疗程耐药的急性髓系白血病患儿的不良预后。

Biol Blood Marrow Transplant. 2016 Dec;22(12):2235-2242. doi: 10.1016/j.bbmt.2016.09.004. Epub 2016 Sep 7.

T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.采用移植后环磷酰胺的T细胞充足的外周血单倍体相合造血细胞移植，在活动性疾病急性髓系白血病中产生的结果与来自传统匹配供体的移植相似。

Biol Blood Marrow Transplant. 2017 Apr;23(4):648-653. doi: 10.1016/j.bbmt.2017.01.068. Epub 2017 Jan 10.

Haploidentical Stem Cell Transplantation for Refractory/Relapsed Neuroblastoma.Haploidentical 干细胞移植治疗难治/复发性神经母细胞瘤。

Biol Blood Marrow Transplant. 2018 May;24(5):1005-1012. doi: 10.1016/j.bbmt.2017.12.805. Epub 2018 Jan 4.

The efficacy of salvage autologous stem cell transplant among patients with multiple myeloma who received maintenance therapy post initial transplant.接受初始移植后维持治疗的多发性骨髓瘤患者中挽救性自体干细胞移植的疗效。

Bone Marrow Transplant. 2018 Nov;53(11):1483-1486. doi: 10.1038/s41409-018-0216-3. Epub 2018 May 24.

Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.使用白消安、氟达拉滨和抗胸腺细胞球蛋白进行减低强度预处理用于缓解期急性髓系白血病患者接受无关或单倍体相合家庭供者造血细胞移植

Biol Blood Marrow Transplant. 2017 Sep;23(9):1555-1566. doi: 10.1016/j.bbmt.2017.05.025. Epub 2017 May 25.

引用本文的文献

[Clinical analysis of 14 patients aged ≤ 50 years with high-risk multiple myeloma treated with allogeneic hematopoietic stem cell transplantation].14例年龄≤50岁高危多发性骨髓瘤患者接受异基因造血干细胞移植的临床分析

Zhonghua Xue Ye Xue Za Zhi. 2024 Jan 14;45(1):28-34. doi: 10.3760/cma.j.cn121090-20230928-00148.

Allogeneic Stem Cell Transplantation in Multiple Myeloma.多发性骨髓瘤中的异基因干细胞移植

Cancers (Basel). 2021 Dec 23;14(1):55. doi: 10.3390/cancers14010055.

Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors.利用自然杀伤细胞同种反应性供体进行多发性骨髓瘤患者的单倍体相合移植。

Ann Hematol. 2021 Jan;100(1):181-187. doi: 10.1007/s00277-020-04303-z. Epub 2020 Oct 28.

Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myeloma.人类白细胞抗原匹配和单倍体造血干细胞移植治疗多发性骨髓瘤的结局比较。

Chin Med J (Engl). 2019 Aug 5;132(15):1765-1772. doi: 10.1097/CM9.0000000000000341.

Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report.Haploidentical 移植治疗复发性多发性骨髓瘤患者的结果：EBMT/CIBMTR 报告。

Biol Blood Marrow Transplant. 2019 Feb;25(2):335-342. doi: 10.1016/j.bbmt.2018.09.018. Epub 2018 Sep 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Safety and efficacy of haploidentical stem cell transplantation for multiple myeloma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献